Summer Sale
50% off Premium Yearly
00days
00hrs
00mins
00secs
Opinions Peter Hodson
Delcath SystemsDCTHTOP PICKJul 22, 2010
Liver cancer treatment. They isolate the liver and then pump more chemo to kill cancer cells. Survivor rate has gone from 4 to 23 months. Market potential is about 5-6 billion globally. Stock dropped when a scientist said it wouldn't work but FDA protocol showed results were significant.
Peter HodsonOwned
$7.43
Stock price when the opinion was issued
$11.72
As of Jun 12, 2026. Market Open.
Consumer Products
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.
